Vericel Stock

Vericel OCF Margin

The Operating Cash Flow Margin of Vericel (VCEL) as of Aug 16, 2026 is 18.79 %. In the previous year, Operating Cash Flow Margin was 24.52 % — a change of -23.36% (lower).

OCF Margin

18.79 %

YoY

-23.36%

Last updated:

Operating Cash Flow Margin of Vericel is 2026 18.79 % . Operating Cash Flow Margin of Vericel was 2025 24.52 % . It decreases by -23.36% lower compared to the previous year.
Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

Operating Cash Flow Margin of Vericel is 18.79 % in 2026.

Operating Cash Flow Margin of Vericel changed from 24.52 % to 18.79 %, representing a -23.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Vericel since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Vericel with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Vericel

All Key Metrics — Vericel